| [1] |
陈万青，李贺，孙可欣, 等. 2014年中国恶性肿瘤发病和死亡分析[J]. 中华肿瘤杂志, 2018, 40(1): 5-13.
|
| [2] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
| [3] |
Lagergren J, Smyth E, Cunningham D, et al. Oesophageal cancer[J]. Lancet 2017, 390(10110): 2383-2396.
|
| [4] |
NCCN clinical practice guidelines: Esophageal and esophagogastric junction cancers[EB/OL].
URL
|
| [5] |
国家卫生健康委员会. 食管癌诊疗规范(2018年版)[J]. 中华消化病与影像杂志(电子版), 2019, 9(4): 158-192.
|
| [6] |
中国临床肿瘤学会指南工作委员会. 2020年中国临床肿瘤学会《食管癌诊疗指南》[M]. 北京: 人民卫生出版社, 2020.
|
| [7] |
Rice TW, Ishwaran H, Ferguson MK, et al. Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer[J]. J Thorac Oncol, 2017, 12(1): 36-42.
|
| [8] |
Ide H, Nakamura T, Hayashi K, et al. Esophageal squamous cell carcinoma: pathology and prognosis[J]. World J Surg, 1994, 18(3): 321-330.
|
| [9] |
Newton AD, Predina JD, Xia L, et al. Surgical management of early-stage esophageal adenocarcinoma based on lymph node metastasis risk[J]. Ann Surg Oncol, 2018, 25(1): 318-325
|
| [10] |
Merkow RP, Bilimoria KY, Keswani RN, et al. Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer[J]. J Natl Cancer Inst, 2014, 106(7): dju133.
|
| [11] |
Tian D, Jiang KY, Huang H, et al. Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study[J]. Ann Transl Med, 2020, 8(6): 292.
|
| [12] |
Raman V, Jawitz OK, Voigt SL, et al. The effect of age on survival after endoscopic resection versus surgery for T1a esophageal cancer[J]. J Thorac Cardiovasc Surg, 2020, 160(1): 295-302.e3.
|
| [13] |
刘宇亭，徐灿，李兆申. 内镜超声在早期食管癌诊断和治疗中的应用[J]. 胃肠病学, 2015, 20(8): 496-499.
|
| [14] |
Thosani N, Singh H, Kapadia A, et al. Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis[J]. Gastrointest Endosc, 2012, 75(2): 242-253.
|
| [15] |
Luo LN, He LJ, Gao XY, et al. Endoscopic ultrasound for preoperative esophageal squamous cell carcinoma: a meta-analysis[J]. PLoS One, 2016, 11(7): e0158373.
|
| [16] |
Reinig JW, Stanley JH, Schabel SI. CT evaluation of thickened esophageal walls[J]. AJR Am J Roentgenol, 1983, 140(5): 931-934.
|
| [17] |
Onbaş O, Eroglu A, Kantarci M, et al. Preoperative staging of esophageal carcinoma with multidetector CT and virtual endoscopy[J]. Eur J Radiol, 2006, 57(1): 90-95.
|
| [18] |
Panebianco V, Grazhdani H, Iafrate F, et al. 3D CT protocol in the assessment of the esophageal neoplastic lesions: can it improve TNM staging?[J]. Eur Radiol, 2006, 16(2): 414-421.
|
| [19] |
Tangoku A, Yamamoto Y, Furukita Y, et al. The new era of staging as a key for an appropriate treatment for esophageal cancer[J]. Ann Thorac Cardiovasc Surg, 2012, 18(3), 190-199.
|
| [20] |
Qu J, Zhang H, Wang Z, et al. Comparison between free-breathing radial VIBE on 3-T MRI and endoscopic ultrasound for preoperative T staging of resectable oesophageal cancer, with histopathological correlation[J]. European radiology, 2018, 28(2): 780-787.
|
| [21] |
Yamada I, Hikishima K, Miyasaka N, et al. Diffusion-tensor MRI and tractography of the esophageal wall ex vivo[J]. J Magn Reson Imaging, 2014, 40(3): 567-576.
|
| [22] |
Yamada I, Hikishima K, Miyasaka N, et al. Esophageal carcinoma: ex vivo evaluation with diffusion-tensor MR imaging and tractography at 7 T[J]. Radiology, 2014, 272(1): 164-173.
|
| [23] |
Qu J, Wang Z, Qin J, et al. MRI features in differentiating mucosal high-grade neoplasia from early invasive squamous cell cancer of the esophagu[J]. European radiology 2020, 30(6): 3455-3461.
|
| [24] |
Takashima S, Takeuchi N, Shiozaki H, et al. Carcinoma of the esophagus: CT vs MR imaging in determining resectability[J]. AJR Am J Roentgenol, 1991, 156(2): 297-302.
|
| [25] |
Lehr L, Rupp N, Siewert JR. Assessment of resectability of esophageal cancer by computed tomography and magnetic resonance imaging[J]. Surgery, 1988, 103(3): 344-350.
|
| [26] |
Tsujimoto H, Matsumoto Y, Kumano I, et al.Distance between the esophageal tumor and the aorta measured by using the contrast-enhanced attenuation on computed tomography for predicting this tumor invading aorta[J]. J Gastroenterol Hepatol, 2013, 28(2): 297-302.
|
| [27] |
Hu Y, Zheng B, Fu JH, et al. Clinical evaluation of endoscopic ultrasonography and CT in the prediction of the resectability of esophageal carcinoma[J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2010, 13(3): 205-209.
|
| [28] |
Santos LM, Jacomelli M, Scordamaglio PR, et al. Endobronchial ultrasound in esophageal cancer-when upper gastrointestinal endoscopy is not enough[J]. J Bras Pneumol, 2019, 45(3): e20180312.
|
| [29] |
Nishimura Y, Osugi H, Inoue K, et al. Bronchoscopic ultrasonography in the diagnosis of tracheobronchial invasion of esophageal cancer[J]. J Ultrasound Med, 2002, 21(1): 49-58.
|
| [30] |
Osugi H, Nishimura Y, Takemura M, et al. Bronchoscopic ultrasonography for staging supracarinal esophageal squamous cell carcinoma: impact on outcome[J]. World J Surg，2003, 27(5): 590-594
|
| [31] |
Wakamatsu T, Tsushima K, Yasuo M, et al. Usefulness of preoperative endobronchial ultrasound for airway invasion around the trachea: esophageal cancer and thyroid cancer[J]. Respiration, 2006, 73(5): 651-657.
|
| [32] |
Garrido T, Maluf-Filho F, Sallum RA, et al.Endobronchial ultrasound application for diagnosis of tracheobronchial tree invasion by esophageal cancer[J]. Clinics(Sao Paulo), 2009, 64(6): 499-504.
|
| [33] |
Omloo JM, van Heijl M, Bergman JJ, et al.Value of bronchoscopy after EUS in the preoperative assessment of patients with esophageal cancer at or above the carina[J]. J Gastrointest Surg, 2008, 12(11): 1874-1879.
|
| [34] |
van Zoonen M, van Oijen MG, van Leeuwen MS, et al. Low impact of staging EUS for determining surgical resectability in esophageal cancer[J]. Surg Endosc, 2012, 26(10): 2828-2834.
|
| [35] |
Preston SR, Clark GW, Martin IG, et al. Effect of endoscopic ultrasonography on the management of 100 consecutive patients with oesophageal and junctional carcinoma[J]. Br J Surg, 2003, 90(10): 1220-1224.
|
| [36] |
Wakelin SJ, Deans C, Crofts TJ, et al. A comparison of computerised tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophago-gastric carcinoma[J]. Eur J Radiol, 2002, 41(2): 161-167.
|
| [37] |
van Vliet EP, Eijkemans MJ, Poley JW, et al. Staging of esophageal carcinoma in a low-volume EUS center compared with reported results from high-volume centers[J]. Gastrointest Endosc, 2006, 63(7): 938-947.
|
| [38] |
Katz S, Ferrara T, Alavi A, et al. PET, CT, and MR imaging for assessment of thoracic malignancy: structure meets function[J]. PET Clin, 2008, 3(3): 395-410.
|
| [39] |
Markl M, Fluckiger J, Lee DC, et al. Velocity quantification by electrocardiography-gated phase contrast magnetic resonance imaging in patients with cardiac arrhythmia: a simulation study based on real time transesophageal echocardiography data in atrial fibrillation[J]. J Comput Assist Tomogr, 2015, 39(3): 422-427.
|
| [40] |
Sakurada A, Takahara T, Kwee TC, et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer[J]. Eur Radiol, 2009, 19(6): 1461-1469
|
| [41] |
Weijs TJ, Goense L, van Rossum PSN, et al.The peri-esophageal connective tissue layers and related compartments: visualization by histology and magnetic resonance imaging[J]. J Anat, 2017, 230(2): 262-271.
|
| [42] |
Quint LE, Glazer GM, Orringer MB. Esophageal imaging by MR and CT: study of normal anatomy and neoplasms[J]. Radiology, 1985, 156(3): 727-731.
|
| [43] |
Petrillo R, Balzarini L, Bidoli P, et al. Esophageal squamous cell carcinoma: MRI evaluation of mediastinum[J]. Gastrointest Radiol, 1990, 15(4): 275-278
|
| [44] |
van Rossum PSN, van Hillegersberg R, Lever FM, et al. Imaging strategies in the management of oesophageal cancer: what's the role of MRI?[J]. Eur Radiol, 2013, 23(7): 1753-1765.
|
| [45] |
Kayani B, Zacharakis E, Ahmed K, et al.Lymph node metastases and prognosis in oesophageal carcinoma-a systematic review[J]. Eur J Surg Oncol, 2011, 37(9): 747-753.
|
| [46] |
Waterman TA, Hagen JA, Peters JH, et al.The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma[J]. Ann Thorac Surg, 2004, 78(4): 1161-1169.
|
| [47] |
Lerut TE, de Leyn P, Coosemans W, et al. Advanced esophageal carcinoma[J]. World J Surg, 1994, 18(3): 379-387
|
| [48] |
傅剑华，谭子辉. 食管癌的分期策略[J]. 临床外科杂志. 2016, 24(7): 521-523.
|
| [49] |
Li B, Li N, Liu S, et al. Does [18 F] fluorodeoxyglucose-positron emission tomography/computed tomography have a role in cervical nodal staging for esophageal squamous cell carcinoma?[J]. J Thorac Cardiovasc Surg, 2020, 160(2): 544-550.
|
| [50] |
Omloo JM, van Heijl M, Smits NJ, et al. Additional value of external ultrasonography of the neck after CT and PET scanning in the preoperative assessment of patients with esophageal cancer[J]. Dig Surg, 2009, 26(1): 43-49.
|
| [51] |
van Vliet EP, Heijenbrok-Kal MH, Hunink MG, et al. Staging investigations for oesophageal cancer: a metaanalysis[J]. Br J Cancer, 2008, 98(3): 547-557.
|
| [52] |
Lee G, IH, Kim SJ, Jeong YJ, et al. Clinical implication of PET/MR imaging in preoperative esophageal cancer staging: comparison with PET/CT, endoscopic ultrasonography, and CT[J]. J Nucl Med, 2014, 55(8): 1242-1247.
|
| [53] |
Wu LF, Wang BZ, Feng JL, et al. Preoperative TN staging of esophageal cancer: comparison of miniprobe ultrasonography, spiral CT and MRI[J]. World J Gastroenterol, 2003, 9(2): 219-224
|
| [54] |
Nishimura H, Tanigawa N, Hiramatsu M, et al.Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall uperparamagnetic iron oxide[J]. J Am Coll Surg, 2006, 202(4): 604-611.
|
| [55] |
Tan X, Ma Z, Yan L, et al. Radiomics nomogram outperforms size criteria in discriminating lymph node metastasis in resectable esophageal squamous cell carcinoma[J]. Eur Radiol. 2019, 29(1): 392-400.
|
| [56] |
Wu L, Yang X, Cao W, et al. Multiple Level CT Radiomics Features Preoperatively Predict Lymph Node Metastasis in Esophageal Cancer:a multicentre retrospective study[J]. Front Oncol, 2020, 9: 1548.
|
| [57] |
Shen C, Liu Z, Wang Z, et al.Building CT Radiomics Based Nomogram for Preoperative Esophageal Cancer Patients Lymph Node Metastasis Prediction[J]. Transl Oncol, 2018, 11(3): 815-824.
|
| [58] |
Qu J, Shen C, Qin J, et al. The MR radiomic signature can predict preoperative lymph node metastasis in patients with esophageal cancer[J]. Eur Radiol, 2019, 29(2): 906-914.
|
| [59] |
Konski A, Doss M, Milestone B, et al.The integration of 18-flfluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma[J]. Int J Radiat Oncol Biol Phys, 2005, 61(4): 1123-1128.
|
| [60] |
Walker AJ, Spier BJ, Perlman SB, et al. Integrated PET/CT fusion imaging and endoscopic ultrasound in the preoperative staging and evaluation of esophageal cancer[J]. Mol Imaging Biol, 2011, 13(1): 166-171.
|
| [61] |
Lin J, Kligerman S, Goel R, et al. State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment[J]. J Gastrointest Oncol, 2015, 6(1): 3-19.
|
| [62] |
Hsu PK, Lin KH, Wang SJ, et al. Preoperative positron emission tomography/computed tomography predicts advanced lymph node metastasis in esophageal squamous cell carcinoma patients[J]. World J Surg, 2011,35(6): 1321-1326.
|
| [63] |
Pepek JM, Willett CG, Czito BG. Technical considerations in radiation therapy for gastroesophageal junction cancer[J]. Semin Radiat Oncol, 2013, 23(1): 51-59.
|
| [64] |
Weber WA, Ott K. Imaging of esophageal and gastric cancer[J]. Semin Oncol, 2004, 31(4): 530-541.
|
| [65] |
Yang H, Liu H, Chen Y, et al; AME Thoracic Surgery Collaborative Group. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus(NEOCRTEC5010): a Phase Ⅲ multicenter, randomized, open-label clinical trial[J]. J Clin Oncol, 2018, 36(27): 2796-2803.
|
| [66] |
Shapiro J, van Lanschot JJB, Hulshof MCCM, et al; CROSS Study Group. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer(CROSS): long-term results of a randomized controlled trial[J]. Lancet Oncol, 2015, 16(9): 1090-1098.
|
| [67] |
van Hagen P, Hulshof MC, van Lanschot JJ, et al; CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer[J]. N Engl J Med, 2012, 366(22): 2074-2084.
|
| [68] |
Swisher SG, Maish M, Erasmus JJ, et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg, 2004, 78(4): 1152-1160.
|
| [69] |
Makino T, Doki Y, Miyata H, et al. Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma[J]. Surgery, 2008, 144(5): 793-802.
|
| [70] |
Ilson DH, Minsky BD, Ku GY, et al. Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer[J]. Cancer, 2012, 118(11): 2820-2827.
|
| [71] |
Triantafyllou T, Wijnhoven B.Multidisciplinary treatment of esophageal cancer: The role of active surveillance after neoadjuvant chemoradiation[J]. Ann Gastroenterol Surg, 2020, 4(4): 352-359.
|
| [72] |
de Gouw DJJM, Klarenbeek BR, Driessen M, et al.Detecting pathological complete response in esophageal cancer after neoadjuvant therapy based on imaging techniques: a diagnostic systematic review and meta-analysis[J]. J Thorac Oncol, 2019, 14(7): 1156-1171.
|
| [73] |
Wang Z, Guo J, Qin J, et al. Accuracy of 3-T MRI for preoperative T staging of esophageal cancer after neoadjuvant chemotherapy, with histopathologic correlation[J]. AJR American journal of roentgenology, 2019: 1-8.
|
| [74] |
van Rossum PSN, Goense L, Meziani J, et al.Endoscopic biopsy and EUS for the detection of pathologic complete response after neoadjuvant chemoradiotherapy in esophageal cancer:a systematic review and meta-analysis[J]. Gastrointest Endosc, 2016, 83(5): 866-879.
|
| [75] |
Sun F, Chen T, Han J, et al. Staging accuracy of endoscopic ultrasound for esophageal cancer after neoadjuvant chemotherapy: a meta-analysis and systematic review[J]. Dis Esophagus, 2015, 28(8): 757-771.
|
| [76] |
Beukinga RJ, Hulshoff JB, et al. Prediction of response to neoadjuvant chemotherapy and radiation therapy with baseline and restaging(18)F-FDG PET imaging biomarkers in oatients with esophageal cancer[J]. Radiology, 2018, 287(3): 983-992.
|
| [77] |
Yang Z, He B, Zhuang X, et al.CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy[J]. J Radiat Res, 2019, 60(4): 538-545.
|
| [78] |
Noordman BJ, Spaander MCW, Valkema R, et al; SANO Study Group. Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer(preSANO):a prospective multicentre, diagnostic cohort study[J]. Lancet Oncol, 2018, 19(7): 965-974.
|
| [79] |
Valkema MJ, van der Wilk BJ, Eyck BM, et al. Surveillance of clinically complete responders using serial(18)F-FDG PET/CT scans in patients with esophageal cancer after neoadjuvant chemoradiotherapy[J]. J Nucl Med, 2020: jnumed.120.247981.
|